Biotech | August 06, 2021
Mark W. Womack is the new CEO of Stelis Biopharma
He will be stationed at the company HQ in Bengaluru, India
He will be stationed at the company HQ in Bengaluru, India
Arrow is the marketing partner in US
Aditya Puri former MD of HDFC bank joins Solara board as chairman
India business is growing as per projections; whereas US business will bounce back soon.
It posted net profit of Rs.147.76 crores for the period ended June 30, 2020.
It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older
The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.
The US business faced price erosion due to increased competition.
Subscribe To Our Newsletter & Stay Updated
